← Leaderboards
Samuel W Terman
University Of Michigan At Ann Arbor
$392,175
Attributed
$392,175
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $196.4K · FY2024–25$200K$150K$100K$50K$0
'24
'25
Funding mix
By agency
NIH$392,175 · 1
By mechanism
K23$392,175 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Robert Silbergleit$19,984,514
- Clifton W Callaway$17,248,303
- William G Barsan$53,624,340
- Lori L Isom$24,363,897
- Andrzej T Galecki$4,595,239
Others in their field
Other Rising Stars on “Adverse Effects”
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,500,724
- Dawn Fallacara · Battelle Centers/Pub Hlth Res & Evaluatn$12,449,418
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
Adverse EffectsAge GroupAge Related ChangesAgingAging RelatedAnticonvulsantsApplied SkillsAutomobile DrivingAwardBeneficiaryCareerCare PreferenceCaringCentral Nervous SystemCentral Nervous System AgentsClinical TrialsCognitionCognitiveCommunitiesCountryData CollectionData SetDisease RemissionAdult
Grant awards (2)
Optimizing antiseizure medication deprescribing decisions across the lifespan by integrating seizure risk prediction and patient preferences towards individualized net-benefit assessment$195,780
K23 · FY2025 · AG · contact PI
Optimizing antiseizure medication deprescribing decisions across the lifespan by integrating seizure risk prediction and patient preferences towards individualized net-benefit assessment$196,395
K23 · FY2024 · AG · contact PI